NCT07212283 Wise Intervention for Reducing Aggressive Behaviors and Promoting Prosocial Behaviors Toward LGB-TNB Individuals
| NCT ID | NCT07212283 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Deusto |
| Condition | Aggression |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2025-09-18 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,000 participants in total. It began in 2025-09-18 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates the effectiveness of a wise Intervention to reduce aggressive behaviors and promote prosocial behaviors toward LGB-TNB individuals among Spanish adolescents. Half of the participants will receive the experimental intervention, while the other half will receive a control intervention.
Eligibility Criteria
Inclusion Criteria: * Informed consent by the adolescents and their families. * To be fluent in Spanish and/or Euskera. Exclusion Criteria: * Lack of permission by families and the adolescent. * Lack of understanding of the instructions.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07212283 clinical trial?
This trial is open to participants of all sexes, aged 14 Years or older, up to 18 Years, studying Aggression. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07212283 currently recruiting?
Yes, NCT07212283 is actively recruiting participants. Contact the research team at nerea.cortazar@deusto.es for enrollment information.
Where is the NCT07212283 trial being conducted?
This trial is being conducted at Bilbao, Spain.
Who is sponsoring the NCT07212283 clinical trial?
NCT07212283 is sponsored by University of Deusto. The trial plans to enroll 1,000 participants.